USPTO serial 88394124
EUROLINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 5, 2021
- Examiner
- SINGER,MELANIE ALYSSA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EUROLINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $650
Owner
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevan L. Morgan
Kevan L. Morgan Seed IP Law Group LLP701 Fifth Avenue, Suite 5400Seattle, WA 98104UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for research; Diagnostic agents and diagnostic substances for scientific purposes, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or a carrier material, in the nature of a microsphere, paper ring, test strip, blot, microtiter plate or membrane | ACTIVE | Jan 16, 2019 |
| 005 | Diagnostic agents, in particular diagnostic agents for medical and veterinary purposes for detection of allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or carrier material, in the nature of a microsphere, test strip, blot, microtiter plate or membrane; Reagents for medical and veterinary diagnostic purposes, namely, veterinary diagnostic reagents and medical diagnostic reagents; Reagents for medical and veterinary diagnosis being veterinary diagnostic reagents and medical diagnostic reagents, in particular immobilised proteins, nucleic acids, allergens and biological tissue sections being cultures on a carrier or a carrier material, in the nature of a microsphere, paper ring, test strip, blot, microtiter plate or membrane | ACTIVE | Jan 16, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named EUROLINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 2, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 29, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 29, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 13, 2020 | IUAF | USE AMENDMENT FILED | — |
| Oct 13, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 26, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 31, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 13, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 31, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 31, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 31, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2019 | NWAP | NEW APPLICATION ENTERED | — |